Vaccheri A, Dall'Olio R, Gandolfi O, Roncada P, Montanaro N
Psychopharmacology (Berl). 1987;91(3):394-6. doi: 10.1007/BF00518199.
Rats were treated for 21 days with the selective D-1 blocker SCH 23390 (0.1 mg/kg SC). Threshold doses of apomorphine for hypermotility (0.15 mg/kg SC) and for stereotyped response (0.25 mg/kg SC) were given 7, 21, 35, and 77 days after discontinuation of the chronic treatment. The rats always showed enhanced stereotyped response to the higher dose of apomorphine but never any change in their motility response to the lower dose of dopamine agonist. This finding may represent a behavioral correlate of the reported supersensitivity of D-1 receptors induced by SCH 23390.
用选择性D-1阻滞剂SCH 23390(0.1毫克/千克,皮下注射)对大鼠进行为期21天的治疗。在慢性治疗停药后的第7、21、35和77天,给予引起运动亢进的阿扑吗啡阈剂量(0.15毫克/千克,皮下注射)和引起刻板反应的阿扑吗啡阈剂量(0.25毫克/千克,皮下注射)。大鼠对较高剂量的阿扑吗啡总是表现出增强的刻板反应,但对较低剂量多巴胺激动剂的运动反应从未有任何变化。这一发现可能代表了所报道的由SCH 23390诱导的D-1受体超敏反应的行为关联。